Traditional A/B testing splits traffic uniformly: 50 percent to control, 50 percent to variant. That’s a sensible design when ...

SOUTH SAN FRANCISCO, Calif., March 25, 2026--(BUSINESS WIRE)--Encoded Therapeutics, Inc. ("Encoded"), a clinical-stage biotechnology company developing precision genetic medicines for severe ...

I never thought smart home tech was for me. Maybe that’s because my introduction to it was largely centered around my friends incessantly yelling “Hey Google!” whenever they wanted a light turned on ...

Quantum machine learning is being explored as the next frontier in cybersecurity, but new research shows it remains far from replacing established artificial intelligence systems in detecting phishing ...

Cases of MenB linked to Canterbury nightclub have risen to 20, with two deaths, as experts warn of ‘explosive’ outbreak Meningitis infections in a county in the south-east of England continue to ...

Sweden’s V-Dem Institute warns that the US is no longer a liberal democracy. And autocracy is creeping across Europe too The US is no longer a democracy. One of the most credible global sources on the ...

For almost a century, psychologists and neuroscientists have been trying to understand how humans memorize different types of information, ranging from knowledge or facts to the recollection of ...

Mr. Bookstaber is the author of “A Demon of Our Own Design,” which in 2007 warned of the potential for a financial crisis. At the start of the 2008 financial crisis, I was at a hedge fund. By its end, ...

In a new study, published in Cell, researchers describe a newfound mechanism for creating proteins in a giant DNA virus, comparable to a mechanism in eukaryotic cells. The finding challenges the dogma ...

New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. If you’ve spent even five minutes scrolling ...

Encoded Therapeutics has linked its Dravet syndrome gene therapy ETX101 to a 78% reduction in seizures, keeping the biotech on track to start a pivotal study next year. The Californian company’s ...